Dr. Kevin Bennewith obtained his PhD in Pathology and Laboratory Medicine at UBC in 2004 under the supervision of Dr. Ralph Durand at BC Cancer. During his PhD training, he studied solid tumour physiology with particular emphasis on quantifying poorly oxygenated (hypoxic) tumour cells. He then joined the laboratory of Dr. Amato Giaccia at Stanford University as a post-doctoral scholar, where he was involved in several projects investigating the role of hypoxia-induced secreted proteins in the growth and metastasis of solid tumours. His post-doctoral work included studying the role of connective tissue growth factor in pancreatic tumour growth and using an orthotopic pancreatic tumour model to study the efficacy of chemotherapeutics designed to target hypoxic tumour cells. He also helped to discover a central role for lysyl oxidase in breast cancer metastasis through promoting the recruitment of bone marrow-derived cells to metastatic target organs. Dr. Bennewith was recruited to BC Cancer in 2008, and since that time his work has been funded by a Terry Fox Foundation New Investigator Operating Grant, the Canadian Institutes of Health Research Institute of Cancer Research, the BC Cancer Foundation, and a Michael Smith Foundation for Health Research Career Investigator Award. 



University of British Columbia


Current Appointment

Professor, Department of Pathology and Laboratory Medicine, UBC

Co-Director, Interdisciplinary Oncology Program, UBC


Post-Doctoral Scholar, Division of Radiation and Cancer Biology, Stanford University (2004-2008)

PhD, Department of Pathology and Laboratory Medicine, UBC (1999-2004)


Distinguished Achievement Award for Excellence in Basic Science Research, Faculty of Medicine, UBC (2017)

Killam Award for Excellence in Mentoring, Faculty of Graduate and Postdoctoral Studies, UBC (2016)

Early Career Excellence in Research and Discovery Award, Department of Pathology and Laboratory Medicine, UBC (2016)

Excellence in Education Award, Department of Pathology and Laboratory Medicine, UBC (2014)

Biomedical Research Scholar, Michael Smith Foundation for Health Research, Career Investigator Award (2011-2019)

Selected Publications

CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.

Oncoimmunology, 2022
Melese, Etienne S, Franks, Elizabeth, Cederberg, Rachel A, Harbourne, Bryant T, Shi, Rocky, Wadsworth, Brennan J, Collier, Jenna L, Halvorsen, Elizabeth C, Johnson, Fraser, Luu, Jennifer, Oh, Min Hee, Lam, Vivian, Krystal, Gerald, Hoover, Shelley B, Raffeld, Mark, Simpson, R Mark, Unni, Arun M, Lam, Wan L, Lam, Stephen, Abraham, Ninan, Bennewith, Kevin L, Lockwood, William W
Back to top